Presentation
Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review. Clin Rheumatol. 2017. 156. [nefrologiaaldia.org]
Treatment
A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis. Kidney Int. 2016;90(3):493-501. 38. Menez SP, El Essawy B, Atta MG. Lupus Nephritis: Current Treatment Paradigm and Unmet Needs. [nefrologiaaldia.org]
Prognosis
Falk RJ, Dall''Era M, Appel, G.B.Treatment and prognosis of diffuse or focal proliferative lupus nephritis: Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc.; 2019 [Available from: http://www.uptodate.com. 111. [nefrologiaaldia.org]
Epidemiology
Insights into the epidemiology and management of lupus nephritis from the US rheumatologist''s perspective. Kidney Int. 2016;90(3):487-92. 96. Malvar A, Pirruccio P, Alberton V, Lococo B, Recalde C, Fazini B, et al. [nefrologiaaldia.org]
Pathophysiology
Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol. 2017;13(8):483-495. 51. McClure M, Jones R. Update on Lupus Nephritis for GPs. Lupus. 2018;27(1_suppl):11-14. 52. [nefrologiaaldia.org]
Prevention
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review. Lupus. 2017;26(14):1463-1472. 187. Liu Y, Kaplan MJ. Cardiovascular disease in systemic lupus erythematosus: an update. [nefrologiaaldia.org]